JAK1 and non-small cell lung carcinoma: The significantly upregulated pathways enriched in the high JAK1 group involved in cell adhesion and tumorigenesis were as follows: regulation of the actin cytoskeleton, focal adhesion, ERBB signaling pathway, MAPK signaling pathway, Toll-like receptor signaling pathway, and non-small cell lung cancer.